Design of HIV-1 protease inhibitors active on multidrug-resistant virus
- PMID: 15771440
- DOI: 10.1021/jm049454n
Design of HIV-1 protease inhibitors active on multidrug-resistant virus
Abstract
On the basis of structural data gathered during our ongoing HIV-1 protease inhibitors program, from which our clinical candidate TMC114 9 was selected, we have discovered new series of fused heteroaromatic sulfonamides. The further extension into the P2' region was aimed at identifying new classes of compounds with an improved broad spectrum activity and acceptable pharmacokinetic properties. Several of these compounds display an exceptional broad spectrum activity against a panel of highly cross-resistant mutants. Certain members of these series exhibit favorable pharmacokinetic profiles in rat and dog. Crystal structures and molecular modeling were used to rationalize the broad spectrum profile resulting from the extension into the P2' pocket of the HIV-1 protease.
Similar articles
-
Discovery and selection of TMC114, a next generation HIV-1 protease inhibitor.J Med Chem. 2005 Mar 24;48(6):1813-22. doi: 10.1021/jm049560p. J Med Chem. 2005. PMID: 15771427
-
Discovery of HIV-1 protease inhibitors with picomolar affinities incorporating N-aryl-oxazolidinone-5-carboxamides as novel P2 ligands.J Med Chem. 2006 Dec 14;49(25):7342-56. doi: 10.1021/jm060666p. J Med Chem. 2006. PMID: 17149864
-
Structure-based design of novel HIV protease inhibitors: sulfonamide-containing 4-hydroxycoumarins and 4-hydroxy-2-pyrones as potent non-peptidic inhibitors.J Med Chem. 1996 Jun 7;39(12):2400-10. doi: 10.1021/jm950888f. J Med Chem. 1996. PMID: 8691434
-
Nonpeptidic potent HIV-1 protease inhibitors.Drug Des Discov. 1996 Apr;13(3-4):15-28. Drug Des Discov. 1996. PMID: 8874041 Review.
-
New drugs for old.J HIV Ther. 2005 Mar;10(1):11-6. J HIV Ther. 2005. PMID: 15951729 Review.
Cited by
-
Darunavir, a conceptually new HIV-1 protease inhibitor for the treatment of drug-resistant HIV.Bioorg Med Chem. 2007 Dec 15;15(24):7576-80. doi: 10.1016/j.bmc.2007.09.010. Epub 2007 Sep 14. Bioorg Med Chem. 2007. PMID: 17900913 Free PMC article. Review.
-
NMR and MD studies combined to elucidate inhibitor and water interactions of HIV-1 protease and their modulations with resistance mutations.J Biomol NMR. 2019 Jul;73(6-7):365-374. doi: 10.1007/s10858-019-00260-6. Epub 2019 Jun 26. J Biomol NMR. 2019. PMID: 31243634 Free PMC article.
-
HIV-1 Protease Inhibitors Incorporating Stereochemically Defined P2' Ligands To Optimize Hydrogen Bonding in the Substrate Envelope.J Med Chem. 2019 Sep 12;62(17):8062-8079. doi: 10.1021/acs.jmedchem.9b00838. Epub 2019 Aug 21. J Med Chem. 2019. PMID: 31386368 Free PMC article.
-
Investigational protease inhibitors as antiretroviral therapies.Expert Opin Investig Drugs. 2016 Oct;25(10):1189-200. doi: 10.1080/13543784.2016.1212837. Epub 2016 Aug 2. Expert Opin Investig Drugs. 2016. PMID: 27415449 Free PMC article. Review.
-
From nonpeptide toward noncarbon protease inhibitors: metallacarboranes as specific and potent inhibitors of HIV protease.Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15394-9. doi: 10.1073/pnas.0507577102. Epub 2005 Oct 14. Proc Natl Acad Sci U S A. 2005. PMID: 16227435 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Chemical Information
